Allscripts (MDRX) Misses Q4 EPS by 1c, FY EPS Guidance Misses
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P, Nasdaq drop on tech selloff as concerns about hawkish Fed, AI spending mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- Oil drops $1 as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Trump announces nuclear deal with Iran, lifts Hormuz blockade
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Allscripts (MDRX) PT Lowered to $14 at Cowen
February 22, 2019 7:12 AM ESTCowen analyst Charles Rhyee lowered the price target on Allscripts (NASDAQ: MDRX) to $14.00 (from $16.00) while maintaining a Outperform rating following the company's 4Q. Adjusted EPS of $0.20 and revenues of $538M missed consensus of $0.21 and $563M, respectively, reflecting impact of weak 3Q bookings.
MDRX introduced... More
